Annual accounts receivable:
$473.57M+$16.13M(+3.53%)Summary
- As of today (May 29, 2025), IDXX annual accounts receivable is $473.57 million, with the most recent change of +$16.13 million (+3.53%) on December 31, 2024.
- During the last 3 years, IDXX annual accounts receivable has risen by +$105.23 million (+28.57%).
- IDXX annual accounts receivable is now at all-time high.
Performance
IDXX Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$527.46M+$53.89M(+11.38%)Summary
- As of today (May 29, 2025), IDXX quarterly accounts receivable is $527.46 million, with the most recent change of +$53.89 million (+11.38%) on March 31, 2025.
- Over the past year, IDXX quarterly accounts receivable has increased by +$20.26 million (+3.99%).
- IDXX quarterly accounts receivable is now -1.15% below its all-time high of $533.61 million, reached on June 30, 2024.
Performance
IDXX Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
IDXX Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.5% | +4.0% |
| 3 y3 years | +28.6% | +31.1% |
| 5 y5 years | +75.8% | +75.8% |
IDXX Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +28.6% | -1.1% | +35.9% |
| 5 y | 5-year | at high | +75.8% | -1.1% | +75.8% |
| alltime | all time | at high | +936.5% | -1.1% | +1054.5% |
IDXX Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $527.46M(+11.4%) |
| Dec 2024 | $473.57M(+3.5%) | $473.57M(-7.4%) |
| Sep 2024 | - | $511.25M(-4.2%) |
| Jun 2024 | - | $533.61M(+5.2%) |
| Mar 2024 | - | $507.21M(+10.9%) |
| Dec 2023 | $457.44M(+14.2%) | $457.44M(+1.0%) |
| Sep 2023 | - | $452.70M(-2.0%) |
| Jun 2023 | - | $461.86M(+3.5%) |
| Mar 2023 | - | $446.02M(+11.3%) |
| Dec 2022 | $400.62M(+8.8%) | $400.62M(+3.2%) |
| Sep 2022 | - | $388.07M(-6.0%) |
| Jun 2022 | - | $412.90M(+2.7%) |
| Mar 2022 | - | $402.24M(+9.2%) |
| Dec 2021 | $368.35M(+11.1%) | $368.35M(-2.2%) |
| Sep 2021 | - | $376.76M(-1.5%) |
| Jun 2021 | - | $382.31M(+0.1%) |
| Mar 2021 | - | $381.79M(+15.2%) |
| Dec 2020 | $331.43M(+23.1%) | $331.43M(-1.8%) |
| Sep 2020 | - | $337.59M(+5.4%) |
| Jun 2020 | - | $320.32M(+6.8%) |
| Mar 2020 | - | $299.98M(+11.4%) |
| Dec 2019 | $269.31M(+8.2%) | $269.31M(+0.4%) |
| Sep 2019 | - | $268.32M(-6.2%) |
| Jun 2019 | - | $286.15M(+1.8%) |
| Mar 2019 | - | $281.16M(+13.0%) |
| Dec 2018 | $248.85M(+6.1%) | $248.85M(-5.9%) |
| Sep 2018 | - | $264.56M(-0.2%) |
| Jun 2018 | - | $265.01M(+2.0%) |
| Mar 2018 | - | $259.87M(+10.8%) |
| Dec 2017 | $234.60M(+14.7%) | $234.60M(+2.8%) |
| Sep 2017 | - | $228.16M(-5.0%) |
| Jun 2017 | - | $240.26M(+6.6%) |
| Mar 2017 | - | $225.35M(+10.2%) |
| Dec 2016 | $204.49M(+8.6%) | $204.49M(-0.1%) |
| Sep 2016 | - | $204.70M(-3.5%) |
| Jun 2016 | - | $212.23M(+0.1%) |
| Mar 2016 | - | $212.07M(+12.6%) |
| Dec 2015 | $188.32M(+23.6%) | $188.32M(-1.4%) |
| Sep 2015 | - | $190.90M(-4.3%) |
| Jun 2015 | - | $199.44M(+1.6%) |
| Mar 2015 | - | $196.23M(+28.8%) |
| Dec 2014 | $152.38M(-3.6%) | $152.38M(-5.0%) |
| Sep 2014 | - | $160.47M(-4.8%) |
| Jun 2014 | - | $168.64M(-6.3%) |
| Mar 2014 | - | $179.92M(+13.8%) |
| Dec 2013 | $158.04M(+14.3%) | $158.04M(+4.3%) |
| Sep 2013 | - | $151.57M(-4.7%) |
| Jun 2013 | - | $159.12M(+0.1%) |
| Mar 2013 | - | $158.99M(+14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $138.32M(-2.1%) | $138.32M(-2.2%) |
| Sep 2012 | - | $141.37M(-3.9%) |
| Jun 2012 | - | $147.16M(-8.6%) |
| Mar 2012 | - | $160.98M(+13.9%) |
| Dec 2011 | $141.28M(+17.7%) | $141.28M(+4.7%) |
| Sep 2011 | - | $134.92M(-9.6%) |
| Jun 2011 | - | $149.31M(+8.6%) |
| Mar 2011 | - | $137.55M(+14.5%) |
| Dec 2010 | $120.08M(+4.3%) | $120.08M(-0.3%) |
| Sep 2010 | - | $120.45M(-5.3%) |
| Jun 2010 | - | $127.14M(-2.6%) |
| Mar 2010 | - | $130.52M(+13.4%) |
| Dec 2009 | $115.11M(+3.2%) | $115.11M(-0.0%) |
| Sep 2009 | - | $115.14M(-3.1%) |
| Jun 2009 | - | $118.78M(+3.1%) |
| Mar 2009 | - | $115.25M(+3.4%) |
| Dec 2008 | $111.50M(+2.9%) | $111.50M(-0.5%) |
| Sep 2008 | - | $112.05M(-7.1%) |
| Jun 2008 | - | $120.56M(-3.7%) |
| Mar 2008 | - | $125.25M(+15.6%) |
| Dec 2007 | $108.38M(+33.2%) | $108.38M(+4.8%) |
| Sep 2007 | - | $103.41M(-3.1%) |
| Jun 2007 | - | $106.68M(+1.8%) |
| Mar 2007 | - | $104.79M(+28.8%) |
| Dec 2006 | $81.39M(+13.5%) | $81.39M(+2.6%) |
| Sep 2006 | - | $79.30M(-6.1%) |
| Jun 2006 | - | $84.47M(+3.1%) |
| Mar 2006 | - | $81.92M(+14.3%) |
| Dec 2005 | $71.69M(+9.2%) | $71.69M(+5.3%) |
| Sep 2005 | - | $68.10M(-6.9%) |
| Jun 2005 | - | $73.14M(-3.3%) |
| Mar 2005 | - | $75.62M(+15.2%) |
| Dec 2004 | $65.64M(+21.6%) | $65.64M(+13.3%) |
| Sep 2004 | - | $57.95M(-2.3%) |
| Jun 2004 | - | $59.29M(-3.5%) |
| Mar 2004 | - | $61.47M(+13.9%) |
| Dec 2003 | $53.98M(+18.1%) | $53.98M(+6.5%) |
| Sep 2003 | - | $50.67M(-0.2%) |
| Jun 2003 | - | $50.78M(-1.5%) |
| Mar 2003 | - | $51.58M(+12.9%) |
| Dec 2002 | $45.69M(-10.0%) | $45.69M(-4.0%) |
| Sep 2002 | - | $47.61M(-0.8%) |
| Jun 2002 | - | $48.00M(-7.1%) |
| Mar 2002 | - | $51.68M(+1.8%) |
| Dec 2001 | $50.77M(-11.3%) | $50.77M(-6.0%) |
| Sep 2001 | - | $53.99M(-4.4%) |
| Jun 2001 | - | $56.48M(-0.6%) |
| Mar 2001 | - | $56.84M(-0.7%) |
| Dec 2000 | $57.27M | $57.27M |
FAQ
- What is IDEXX Laboratories annual accounts receivable?
- What is the all time high annual accounts receivable for IDEXX Laboratories?
- What is IDEXX Laboratories annual accounts receivable year-on-year change?
- What is IDEXX Laboratories quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly accounts receivable year-on-year change?
What is IDEXX Laboratories annual accounts receivable?
The current annual accounts receivable of IDXX is $473.57M
What is the all time high annual accounts receivable for IDEXX Laboratories?
IDEXX Laboratories all-time high annual accounts receivable is $473.57M
What is IDEXX Laboratories annual accounts receivable year-on-year change?
Over the past year, IDXX annual accounts receivable has changed by +$16.13M (+3.53%)
What is IDEXX Laboratories quarterly accounts receivable?
The current quarterly accounts receivable of IDXX is $527.46M
What is the all time high quarterly accounts receivable for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly accounts receivable is $533.61M
What is IDEXX Laboratories quarterly accounts receivable year-on-year change?
Over the past year, IDXX quarterly accounts receivable has changed by +$20.26M (+3.99%)